Professor | Jun Wan | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Jun Wan
Contact Information	wanjun@whu.edu.cn
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Jun Wan

Contact Information

wanjun@whu.edu.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1980.09-1985.06 Bachelor of Clinical Medicine from Xianning Medical College 1988.09-1991.06 Master of Internal Medicine from Hubei Medical University (now Wuhan University First Clinical College) 1999.09-2002.06 PhD in Internal Medicine from Wuhan University First Clinical College Has educated 18 master's students and 8 doctoral students
Work Experience	1985.07-1988.09 Assistant at Xianning Medical College 1991.07-1999.09 Attending Physician, Associate Chief Physician at Wuhan Fifth Hospital, Department of Cardiology 2002.07-Present Chief Physician, Professor at Renmin Hospital of Wuhan University, Department of Cardiology 2012.12-2021.12 Vice President of Renmin Hospital of Wuhan University 2020.02-2020.03 President of Wuchang Fangcang Hospital 2022.01-Present Deputy Director of the Teaching Steering Committee, also serving as Deputy Director of the Institute of Cardiovascular Diseases at Renmin Hospital of Wuhan University
Awards	2018 Excellent Product Award at the 20th China International High-tech Achievement Fair for the study on 'AI-based 'Active 120' New Health Care and Emergency Critical Care Service Model' 2020 National Health System Advanced Individual in COVID-19 Epidemic Prevention and Control 2022 Second Prize in Hubei Province Science and Technology Progress Award for 'Innovation in Immune Mechanism and Prevention Strategy of Hypertension and its Complications'

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1980.09-1985.06 Bachelor of Clinical Medicine from Xianning Medical College
1988.09-1991.06 Master of Internal Medicine from Hubei Medical University (now Wuhan University First Clinical College)
1999.09-2002.06 PhD in Internal Medicine from Wuhan University First Clinical College
Has educated 18 master's students and 8 doctoral students

Work Experience

1985.07-1988.09 Assistant at Xianning Medical College
1991.07-1999.09 Attending Physician, Associate Chief Physician at Wuhan Fifth Hospital, Department of Cardiology
2002.07-Present Chief Physician, Professor at Renmin Hospital of Wuhan University, Department of Cardiology
2012.12-2021.12 Vice President of Renmin Hospital of Wuhan University
2020.02-2020.03 President of Wuchang Fangcang Hospital
2022.01-Present Deputy Director of the Teaching Steering Committee, also serving as Deputy Director of the Institute of Cardiovascular Diseases at Renmin Hospital of Wuhan University

Awards

2018 Excellent Product Award at the 20th China International High-tech Achievement Fair for the study on 'AI-based 'Active 120' New Health Care and Emergency Critical Care Service Model'
2020 National Health System Advanced Individual in COVID-19 Epidemic Prevention and Control
2022 Second Prize in Hubei Province Science and Technology Progress Award for 'Innovation in Immune Mechanism and Prevention Strategy of Hypertension and its Complications'

Areas of Focus	Inflammation and cardiovascular diseases AI and Internet plus medical applications Medical Device Regulation Science
Publications	Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients, Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B, He H, Wang Z, Ye D, Zhao M, Luo Z, Liu M, Zhang P, Gu J, Liu M, Li D, Liu J, Wan J, 2020 The expression of interleukin 20 increases in plasma and aortic tissues from patients with acute aortic dissection, Zhang J, Liu J, Zhao M, Ye J, Xu Y, Wang Z, Ye D, Ding W, Li D, Liu M, Wang M, Wan J, 2020 The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis, Ye J, Wang Y, Wang Z, Liu L, Yang Z, Wang M, Xu Y, Ye D, Zhang J, Zhou Q, Lin Y, Ji Q, Wan J, 2020 Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction and elevates blood pressure in angiotensin II-infused mice, Ye J, Que B, Huang Y, Lin Y, Chen J, Liu L, Shi Y, Wang Y, Wang M, Zeng T, Wang Z, Hu H, Xu Y, Shi L, Ye D, Liu J, Jiang H, Wan J, Ji Q, 2019 Serum Levels of Complement-C1q/Tumor Necrosis Factor-Related Protein-3 Decreased in Patients With Acute Aortic Dissection, Jiang H, Wang M, Ye J, Liu J, Wang Z, Xu Y, Ye D, Wan J, 2018 Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients, Ye J, Wang Y, Wang Z, Ji Q, Huang Y, Zeng T, Hu H, Ye D, Wan J, Lin Y, 2018 Interleukin 22 promotes blood pressure elevation and endothelial dysfunction in angiotensin II-treated mice, Ye J, Ji Q, Liu J, Liu L, Huang Y, Shi Y, Shi L, Wang M, Liu M, Feng Y, Jiang H, Xu Y, Wang Z, Song J, Lin Y, Wan J, 2017 Increased levels of interleukin-22 in thoracic aorta and plasma from patients with acute thoracic aortic dissection, Ye, J; Wang, M; Jiang, H; Ji, Q; Huang, Ying; Liu, J; Zeng, Tao; Xu, Y; Wang, Z; Lin, Y; Wan, J*, 2017

Areas of Focus

Inflammation and cardiovascular diseases
AI and Internet plus medical applications
Medical Device Regulation Science

Publications

Clinical Features of COVID-19 in Patients With Essential Hypertension and the Impacts of Renin-angiotensin-aldosterone System Inhibitors on the Prognosis of COVID-19 Patients, Pan W, Zhang J, Wang M, Ye J, Xu Y, Shen B, He H, Wang Z, Ye D, Zhao M, Luo Z, Liu M, Zhang P, Gu J, Liu M, Li D, Liu J, Wan J*, 2020
The expression of interleukin 20 increases in plasma and aortic tissues from patients with acute aortic dissection, Zhang J, Liu J, Zhao M, Ye J, Xu Y, Wang Z, Ye D, Ding W, Li D, Liu M, Wang M*, Wan J*, 2020
The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis, Ye J, Wang Y, Wang Z, Liu L, Yang Z, Wang M, Xu Y, Ye D, Zhang J, Zhou Q, Lin Y*, Ji Q*, Wan J*, 2020
Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction and elevates blood pressure in angiotensin II-infused mice, Ye J, Que B, Huang Y, Lin Y, Chen J, Liu L, Shi Y, Wang Y, Wang M, Zeng T, Wang Z, Hu H, Xu Y, Shi L, Ye D, Liu J, Jiang H, Wan J*, Ji Q*, 2019
Serum Levels of Complement-C1q/Tumor Necrosis Factor-Related Protein-3 Decreased in Patients With Acute Aortic Dissection, Jiang H, Wang M, Ye J, Liu J, Wang Z, Xu Y, Ye D, Wan J*, 2018
Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients, Ye J, Wang Y, Wang Z, Ji Q, Huang Y, Zeng T, Hu H, Ye D, Wan J*, Lin Y*, 2018
Interleukin 22 promotes blood pressure elevation and endothelial dysfunction in angiotensin II-treated mice, Ye J, Ji Q, Liu J, Liu L, Huang Y, Shi Y, Shi L, Wang M, Liu M, Feng Y, Jiang H, Xu Y, Wang Z, Song J, Lin Y*, Wan J*, 2017
Increased levels of interleukin-22 in thoracic aorta and plasma from patients with acute thoracic aortic dissection, Ye, J; Wang, M; Jiang, H; Ji, Q; Huang, Ying; Liu, J; Zeng, Tao; Xu, Y; Wang, Z; Lin, Y*; Wan, J*, 2017

Inflammation Cardiovascular Disease Interleukins Macrophages Therapeutic Targets Ai Health Management Medical Devices Regulation

Mengyao Ji - Wuhan University

Xuan Xiao - Wuhan University

Zhang Longjiang - Nanjing University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us